Effects of novel Fufang Biejia Ruangan Tablets with sheep placenta as substitute for Hominis Placenta on CCl / 中草药·英文版
Baode SHEN; Yuan LIU; Chengying SHEN; Xiao LIU; Hailong YUAN; Li DENG; Yinchao LI; Ruisheng LI; Li DENG; Baode SHEN; Yuan LIU; Chengying SHEN; Xiao LIU; Hailong YUAN; Li DENG; Yinchao LI; Ruisheng LI; Li DENG.
Chinese Herbal Medicines
; (4): 104-110, 2022.
Artículo
en Zh
| WPRIM | ID: wpr-953617
Objective:
Fufang Biejia Ruangan Tablet (FBRT) is widely used for the treatment of liver fibrosis. However, Hominis Placenta (HP), as an important adjuvant of FBRT, has been restricted for medicinal using due to the limited availability, ethical controversy and safety issues. The present study aimed to investigate the therapeutic effects of novel FBRT (N-FBRT) with sheep placenta (SP) as substitute for HP on liver fibrosis and explore its possible mechanisms. Different dosages of SP in N-FBRT were also evaluated.Methods:
Rats were subcutaneously injected with CCl
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados